103 related articles for article (PubMed ID: 2618564)
1. [Proliferative activity of granulocyte progenitors from the bone marrow of patients with chronic myeloid leukemia in 14-day culture in vivo].
Hansz J; Kozłowska-Skrzypczak M
Acta Haematol Pol; 1989; 20(1):29-35. PubMed ID: 2618564
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human granulopoiesis by macrophage-derived growth regulators.
Hansz J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):3-7. PubMed ID: 2472324
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
[TBL] [Abstract][Full Text] [Related]
6. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
[TBL] [Abstract][Full Text] [Related]
7. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
[TBL] [Abstract][Full Text] [Related]
8. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.
Osterholz J; Dowding C; Guo AP; Siczkowski M; Goldman JM
Exp Hematol; 1991 Jun; 19(5):326-31. PubMed ID: 2026184
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
11. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W
Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914
[TBL] [Abstract][Full Text] [Related]
12. Potent antileukemic activity of the novel agents norsegoline and dibezine.
Einat M; Nagler A; Lishner M; Amiel A; Yarkoni S; Rudi A; Gellerman G; Kashman Y; Fabian I
Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
[TBL] [Abstract][Full Text] [Related]
13. Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia.
Schwab R; Peschel C; Desprès D; Derigs G; Fischer T; Huber C; Aulitzky WE
Cytokines Mol Ther; 1995 Dec; 1(4):281-8. PubMed ID: 9384681
[TBL] [Abstract][Full Text] [Related]
14. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M
Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
16. Rapid decline of clonogenic hemopoietic progenitors in semisolid cultures of bone marrow samples derived from patients with chronic myeloid leukemia.
Wandl U; Messner HA
Int J Cell Cloning; 1989 Sep; 7(5):314-21. PubMed ID: 2768845
[TBL] [Abstract][Full Text] [Related]
17. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors.
Ivanović Z; Bartolozzi B; Bernabei PA; Cipolleschi MG; Milenkovic P; Praloran V; DelloSbarba P
Stem Cells; 1999; 17(4):219-25. PubMed ID: 10437985
[TBL] [Abstract][Full Text] [Related]
18. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
19. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
20. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
